Palantir Technologies, Inc. (NASDAQ:PLTR) is one of the best stocks to buy according to Jim Simons’ Renaissance Technologies. On October 6, OneMedNet Corporation announced a multi-year partnership with Palantir Technologies (NASDAQ;PLTR) to transform healthcare AI and Real-World Data (RWD) analytics.
Palantir’s Artificial Intelligence Platform will power OneMedNet’s iRWD network, enabling life sciences and research organizations to access anonymized, regulatory-grade clinical data and advanced analytics. This collaboration aims to unlock the $868 billion AI-driven healthcare market by 2030 through scalable, secure, and compliant data solutions.
The integration gives OneMedNet access to over 5 billion claims and 131 million clinical exams across 1,750+ provider sites. Palantir’s platform enhances data discovery, cohort customization, and productivity through conversational AI and automation. Together, the companies will streamline clinical research, accelerate diagnostics and therapeutics, and expand global market reach, all while ensuring compliance with healthcare standards and data privacy regulations.
Palantir Technologies, Inc. (NASDAQ:PLTR) is a software and data analytics company. It develops platforms that help governments, corporations, and institutions integrate, manage, and analyze large datasets to drive decision-making. Its core products include Palantir Gotham, Palantir Foundry, Palantir Apollo, and the Artificial Intelligence Platform (AIP).
While we acknowledge the potential of PLTR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 13 Best Performing NASDAQ Stocks According to Hedge Funds and 10 High-Growth Semiconductor Stocks That Are Profitable in 2025.
Disclosure: None. This article is originally published at Insider Monkey.